ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

BOSUTINIBUM

Active substance (INN) · ATC L01EA04 · 6 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
L01XE14	BOSUTINIBUM	In force	medicine of the protocol	C2-P3	YES

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
BOSULIF 100 mg	COMPR. FILM.	100 mg	PFIZER EUROPE MA EEIG - BELGIA	L01EA04	PR
BOSULIF 400 mg	COMPR. FILM.	400mg	PFIZER EUROPE MA EEIG - BELGIA	L01EA04	PR
BOSULIF 500 mg	COMPR. FILM.	500 mg	PFIZER EUROPE MA EEIG - BELGIA	L01EA04	PR
BOSUTINIB TEVA 100 mg	COMPR. FILM.	100mg	TEVA PHARMACEUTICALS S.R.L. - ROMANIA	L01EA04	PR
BOSUTINIB TEVA 400 mg	COMPR. FILM.	400mg	TEVA PHARMACEUTICALS S.R.L. - ROMANIA	L01EA04	PR
BOSUTINIB TEVA 500 mg	COMPR. FILM.	500mg	TEVA PHARMACEUTICALS S.R.L. - ROMANIA	L01EA04	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.